PURA VIDA INVESTMENTS, LLC - ESPERION THERAPEUTICS INC NE ownership

ESPERION THERAPEUTICS INC NE's ticker is ESPR and the CUSIP is 29664W105. A total of 128 filers reported holding ESPERION THERAPEUTICS INC NE in Q3 2023. The put-call ratio across all filers is 0.13 and the average weighting 0.1%.

Quarter-by-quarter ownership
PURA VIDA INVESTMENTS, LLC ownership history of ESPERION THERAPEUTICS INC NE
ValueSharesWeighting
Q4 2022$1,920,790
-13.7%
308,313
-7.2%
0.10%
-23.3%
Q3 2022$2,225,000
+64.9%
332,123
+56.6%
0.13%
+65.4%
Q2 2022$1,349,000
-36.9%
212,123
+514.8%
0.08%
-92.9%
Q2 2015$2,139,000
+15.5%
34,500
+72.5%
1.10%
+14.5%
Q1 2015$1,852,000
+489.8%
20,000
+157.7%
0.96%
+724.1%
Q4 2014$314,0007,7600.12%
Other shareholders
ESPERION THERAPEUTICS INC NE shareholders Q3 2023
NameSharesValueWeighting ↓
Meditor Group Ltd 4,468,835$27,840,84218.82%
Ikarian Capital, LLC 1,891,147$11,781,8462.84%
Altium Capital Management LP 620,000$3,862,6001.96%
Ikarian Capital, LLC 1,296,900$8,079,6871.95%
Parkman Healthcare Partners LLC 822,784$5,125,9441.36%
Deep Track Capital, LP 4,000,000$24,920,0001.05%
Monaco Asset Management SAM 470,100$2,928,7230.88%
BRAIDWELL LP 3,393,405$21,140,9130.71%
Telemetry Investments, L.L.C. 71,000$4420.70%
Rhenman & Partners Asset Management AB 900,000$5,607,0000.58%
View complete list of ESPERION THERAPEUTICS INC NE shareholders